Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: Initial clinical experience in 1263 patients

Journal of Nuclear Cardiology

Volumn 17, Issue 5, 2010, Pages 853-857

  Kwon, Deborah H ^a   Cerqueira, Manuel D ^a   Young, Ron ^a   Houghtaling, Penny ^a   Lieber, Elizabeth ^a   Menon, Venu ^a   Brunken, Richard C ^a   Jaber, Wael A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

A2A adenosine receptor agonists; myocardial perfusion imaging; regadenoson; SPECT; vasodilator stress

Indexed keywords

REGADENOSON; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; ASTHMA; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE MEASUREMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DRUG TOLERABILITY; DYSPNEA; EXERCISE INTENSITY; EXERCISE TEST; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MYOCARDIAL PERFUSION IMAGING; NAUSEA; PATIENT SAFETY; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; SINGLE DRUG DOSE; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREADMILL EXERCISE;

ADULT; AGED; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PURINES; PYRAZOLES; RECEPTOR, ADENOSINE A2A; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77956965037     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-010-9229-z     Document Type: Article

References (20)

1. MD Cerqueira MS Verani M Schwaiger J Heo AS Iskandrian 1994 Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry J Am Coll Cardiol 23 2 384 389 1:STN:280: DyaK2c7isVyhuw%3D%3D 10.1016/0735-1097(94)90424-3 8294691
2. KK Balan M Critchley 2001 Is the dyspnea during adenosine cardiac stress test caused by bronchospasm? Am Heart J 142 1 142 145 1:STN:280: DC%2BD3MznsValuw%3D%3D 10.1067/mhj.2001.116070 11431670 (Pubitemid 32595386)
3. AE Iskandrian TM Bateman L Belardinelli B Blackburn MD Cerqueira RC Hendel, et al. 2007 Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial J Nucl Cardiol 14 5 645 658 10.1016/j.nuclcard.2007.06.114 17826318 (Pubitemid 47355078)
4. BR Leaker B O'Connor TT Hansel PJ Barnes L Meng VS Mathur, et al. 2008 Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial J Nucl Cardiol 15 3 329 336 10.1016/j.nuclcard.2008.02.009 18513639
5. HD Lieu JC Shryock GO von Mering T Gordi B Blackburn AW Olmsted, et al. 2007 Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans J Nucl Cardiol 14 4 514 520 10.1016/j.nuclcard.2007.02.016 17679059 (Pubitemid 47163555)
6. GS Thomas BR Tammelin GL Schiffman R Marquez DL Rice D Milikien, et al. 2008 Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial) J Nucl Cardiol 15 3 319 328 10.1016/j.nuclcard.2008.02.013 18513638
7. Cerqueira MD, Nguyen P, Staehr S, Underwood R, Iskandrian AE, on behalf of the ADVANCE-MPI Trial Investigators. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging: Integrated ADVANCE-MPI trial results. J Am Coll Cardiol Imaging 2008;1(3):307-16.
8. RC Hendel TM Bateman MD Cerqueira AE Iskandrian JA Leppo B Blackburn, et al. 2005 Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging J Am Coll Cardiol 46 11 2069 2075 1:CAS:528:DC%2BD2MXht1Onur7P 10.1016/j.jacc.2005.05.097 16325044 (Pubitemid 41713594)
9. G Germano PB Kavanagh J Chen P Waechter HT Su H Kiat, et al. 1995 Operator-less processing of myocardial perfusion SPECT studies J Nucl Med 36 11 2127 2132 1:STN:280:DyaK28%2FkvFWitQ%3D%3D 7472609
10. DS Berman R Hachamovitch H Kiat I Cohen JA Cabico FP Wang, et al. 1995 Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography J Am Coll Cardiol 26 3 639 647 1:STN:280:DyaK2MzntVGhug%3D%3D 10.1016/0735-1097(95)00218-S 7642853
11. G Germano H Kiat PB Kavanagh M Moriel M Mazzanti HT Su, et al. 1995 Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 11 2138 2147 1:STN:280:DyaK28%2FkvFWiuw%3D%3D 7472611
12. GS Thomas RC Thompson MI Miyamoto TK Ip DL Rice D Milikien, et al. 2009 The RegEx trial: A randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging J Nucl Cardiol 16 1 63 72 10.1007/s12350-008-9001-9 19152130
13. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J. International union of pharmacology XXV nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53(4):527-52.
14. JC Shryock L Belardinelli 1997 Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology Am J Cardiol 79 12A 2 10 1:CAS:528:DyaK2sXltFChtro%3D 10.1016/S0002-9149(97)00256-7 9223356
15. BD Bertolet L Belardinelli EA Franco WW Nichols RA Kerensky JA Hill 1996 Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans Circulation 93 10 1871 1876 1:CAS:528:DyaK28Xjs1Sku7o%3D 8635266
16. AK Dhalla MY Wong WQ Wang I Biaggioni L Belardinelli 2006 Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats J Pharmacol Exp Ther 316 2 695 702 1:CAS:528:DC%2BD28XhtlWqsbY%3D 10.1124/jpet.105.095323 16227469 (Pubitemid 43130996)
17. AK Dhalla JC Shryock R Shreeniwas L Belardinelli 2003 Pharmacology and therapeutic applications of A1 adenosine receptor ligands Curr Top Med Chem 3 4 369 385 1:CAS:528:DC%2BD3sXntVGjug%3D%3D 10.2174/1568026033392246 12570756
18. Z Gao Z Li SP Baker RD Lasley S Meyer E Elzein, et al. 2001 Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: Inverse relationship between affinity and duration of action of A2A agonists J Pharmacol Exp Ther 298 1 209 218 1:CAS:528:DC%2BD3MXksFChtbk%3D 11408544
19. JN Trochu G Zhao H Post X Xu L Belardinelli FL Belloni, et al. 2003 Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: Potential for use in myocardial perfusion imaging J Cardiovasc Pharmacol 41 1 132 139 1:CAS:528:DC%2BD38Xpslaktbk%3D 10.1097/00005344-200301000-00017 12500031 (Pubitemid 36015065)
20. MD Cerqueira MS Verani M Schwaiger J Heo AS Iskandrian 1994 Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Trial Registry J Am Coll Cardiol 23 2 384 389 1:STN:280: DyaK2c7isVyhuw%3D%3D 10.1016/0735-1097(94)90424-3 8294691